|1.||Kato, N: 2 articles (04/2003 - 08/2001)|
|2.||Li, Guoan: 1 article (08/2014)|
|3.||Dai, Min: 1 article (08/2014)|
|4.||Miao, Jun: 1 article (08/2014)|
|5.||Wood, Kirkham B: 1 article (08/2014)|
|6.||Wan, Zongmiao: 1 article (08/2014)|
|7.||Wiradjaja, Fenny: 1 article (11/2013)|
|8.||Smyth, Ian: 1 article (11/2013)|
|9.||Cottle, Denny L: 1 article (11/2013)|
|10.||Jones, Lynelle: 1 article (11/2013)|
|1.||Congenital Abnormalities (Deformity)
08/01/2014 - "FRAs have been widely used in various degenerative lumbar spine disorders and in adult deformity to achieve interbody fusions with promising results. "
08/01/2014 - "Both PEEK cages and FRAs can significantly increase disk space height and achieve similar clinical outcomes in treating adult spinal deformity fused to the sacrum. "
08/01/2014 - "From March 2006 to February 2010, we analyzed 48 patients (mean age, 56.3±13.9 y) of 61 consecutive adult patients with global coronal and sagittal adult spine deformities who underwent first stage ALIF using PEEK cages or FRAs at L4-L5, L5-S1 segments followed by long (>6 levels) posterior instrumentation. "
08/01/2014 - "PEEK cages have gained increasing popularity of late; however, there is little documentation to the radiographic comparisons between PEEK cages and FRAs used in patients with adult spine deformity treated with long fusions to the sacrum. "
08/01/2014 - "To radiographically evaluate sagittal plane profile and fusion rates of polyetheretherketone (PEEK) cages versus femoral ring allografts (FRAs) in patients with adult spinal deformity fused to the sacrum. "
02/01/2002 - "Studies have addressed the relevance of c-Jun and c-Fos proteins in cancer development. "
01/01/2004 - "Immunostaining for JunB and c-Fos proteins was positive in the nuclei of tumor cells of all TC. "
06/01/1989 - "c-myc and c-fos proteins are found not only in tumor cells but also in stromal cells including macrophages and fibroblast around the tumors. "
06/01/2011 - "Tumors developed on transgenic mice were prone to malignant progression and lymph node metastasis and displayed increased activation of c-Jun-NH2-kinase (JNK) and the downstream c-Jun and c-Fos proteins. "
04/11/2003 - "Compared with the 1 mg/kg pyridoxine diet, 7, 14 and 35 mg/kg pyridoxine diets significantly suppressed the incidence and number of colon tumors, colon cell proliferation and expressions of c-myc and c-fos proteins. "
11/23/1987 - "These results suggest that seizure activity induces the formation of c-fos proteins in selective brain regions, and raise the possibility that c-fos proteins play as yet undetermined physiological and/or pathological roles in the mature brain."
01/01/1994 - "The results showed that seizures can induce c-fos proteins in some nuclei related with seizure and that electroacupuncture can also regulates the c-fos expression after seizure."
01/01/1994 - "Three hours following seizures there was an evident expression of c-fos proteins in the hippocampus (CA1 area), dentate gyrus, piriform cortex, dorsal part of entorhinal cortex, and amygdaloid nucleus, and there was a dramatic increase of c-fos proteins in CA3 area and the areas mentioned above except the CA1 area where c-fos proteins apparently decreased after electroacupuncture treatment. "
11/01/1995 - "We show that delta FosB, a truncated splice variant of FosB, responds like the other acute Fras: it is induced rapidly and transiently in cerebral cortex after acute electroconvulsive seizure (ECS) and in striatum after acute cocaine but does not accumulate after chronic ECS or cocaine treatment. "
01/01/1994 - "C-fos proteins were visualized immunohistochemically in the brain of rats after seizures induced by injecting penicillin into hippocampus and by penicillin+electroacupuncture treatment. "
10/01/2012 - "To develop and analyze a fetal risk assessment score (FRAS) that incorporates fetal arterial and venous blood flow studies (BFS), amniotic fluid volume, the non-stress test (NST) and an estimated fetal weight to improve the ability of antenatal testing to identify fetuses at risk for poor perinatal outcome and compare it to the Biophysical Profile (BPP). "
07/15/1999 - "More than 20 other FRAs, including those that induced thrombocytopenia in chimpanzee A-264, had no effect on platelet count in this monkey. "
07/15/1999 - "This report describes the occurrence of thrombocytopenia in one chimpanzee and one rhesus monkey upon administration of potent FRAs. "
07/15/1999 - "Most clinical trials with fibrinogen receptor antagonists (FRAs) have been associated with thrombocytopenia. "
07/15/1999 - "Chimpanzee A-264 experienced profound thrombocytopenia on two occasions immediately upon intravenous administration of two different potent FRAs, L-738, 167 and L-739,758. "
|1.||Proteins (Proteins, Gene)
|2.||Proto-Oncogene Proteins c-fos (FRAs)
|3.||Transcription Factor AP-1 (Transcription Factor AP 1)
|4.||NF-kappa B (NF-kB)
|5.||Messenger RNA (mRNA)
|6.||Epidermal Growth Factor Receptor (EGF Receptor)
|7.||Glutathione S-Transferase pi
|2.||Homologous Transplantation (Allograft)